Investor relations

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than ten years developing Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the US, among other countries.

Both nasal congestion and migraines affect a large number of people globally. The treatment for nasal congestion is available in the Nordic countries, the EU, Israel and Saudi Arabia. We are currently conducting important clinical studies in both of these areas of therapy.

K.O.S can be an almost side-effect free alternative to medication for migraines. It is fast, pain-free and cheap. The method is based on so-called neuromodulation, which is an area that is growing rapidly within several medical fields. Our goal is to be an important contributor to this development.

Our investors see the enormous potential that exists in a treatment that is cheap, fast and has minimal side effects for migraine and rhinitis.

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

IR contact